Clinical Practice Guidelines
Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients
Version of Record online: 17 APR 2014
© 2014 Wiley Periodicals, Inc.
Pediatric Blood & Cancer
Volume 61, Issue 8, pages 1506–1512, August 2014
How to Cite
Dupuis, L. L., Robinson, P. D., Boodhan, S., Holdsworth, M., Portwine, C., Gibson, P., Phillips, R., Maan, C., Stefin, N. and Sung, L. (2014), Guideline for the prevention and treatment of anticipatory nausea and vomiting due to chemotherapy in pediatric cancer patients. Pediatr. Blood Cancer, 61: 1506–1512. doi: 10.1002/pbc.25063
- Issue online: 10 JUN 2014
- Version of Record online: 17 APR 2014
- Manuscript Accepted: 18 MAR 2014
- Manuscript Received: 14 JAN 2014
- antineoplastic agents;
- supportive care;
This guideline provides an approach to the prevention and treatment of anticipatory chemotherapy-induced nausea and vomiting (CINV) in children. It was developed by an international, inter-professional panel using AGREE II methods and is based on systematic literature reviews. Evidence-based recommendations for pharmacological and non-pharmacological interventions to prevent and treat anticipatory CINV in children receiving antineoplastic agents are provided. Gaps in the evidence used to support the recommendations are identified. The contribution of this guideline to anticipatory CINV control in children requires prospective evaluation. Pediatr Blood Cancer 2014; 61:1506–1512. © 2014 Wiley Periodicals, Inc.